Clinical trial
The Guiding Value of Tumor Micronecrosis for Using Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
NCT05352204 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Guiding Value of Tumor Micronecrosis for Using Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
- Lead sponsor
- Zhejiang University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2020
- Completion date
- April 14, 2022
- Enrollment
- 900 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.